Direct Oral Challenge for Penicillin Allergy: The International Network of Antibiotic Allergy Nations (iNAAN) Study
Clinical Infectious Diseases · 08.07.2026 · 82 (6) · e1148-e1162
DOI: 10.1093/cid/ciag082 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 01.04.2026. Verfasst von Elise A Mitri und 51 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Immunology, Centre for Antibiotic Allergy and Research, Austin Health, Heidelberg, Victoria, Australia. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Hypersensitivity, Penicillins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Allergy Centre of Excellence, Murdoch Children's Research Institute, Victorian Government's Operational Infrastructure Support Program.
Abstract (Originalsprache)
Background
Approximately 10% of hospitalized patients globally report a penicillin allergy, leading to inappropriate antibiotic prescribing and inferior healthcare outcomes. Evidence supporting the effectiveness and widespread implementation of inpatient penicillin direct oral challenge (DOC) is limited.
Methods
A prospective, multicenter, international type 2 hybrid effectiveness-implementation study was conducted in 40 hospitals across 8 countries between November 2022 and May 2025. Adult inpatients with a penicillin allergy underwent assessment using a digital penicillin allergy toolkit (National Antibiotic Allergy Network [NAAN] App). According to site clinical practice, participants received penicillin DOC (effectiveness intervention) or assessment only. Participating sites received bimonthly audit and feedback at least 3 months after site activation (implementation strategy). Observational data were used to emulate a target trial to examine secondary effectiveness outcomes, including antibiotic prescribing at 90 days in DOC versus non-DOC participants. The primary implementation outcome was adoption of the NAAN App within 6 months of site activation.
Results
Among 5121 participants assessed, 1573 (30.7%) underwent DOC, of which 1502 (95.5%) were delabeled. Of 71 (4.5%) participants with a positive DOC, 6 (0.4%) had a serious adverse event. Of 1852 inpatients in the target trial analysis, 892 underwent DOC and 960 underwent assessment only. Participants who underwent DOC were more likely to be prescribed penicillin (risk ratio [RR], 13.25 [95% confidence interval {CI}, 7.82–22.46]), and less likely to be prescribed World Health Organization (WHO) “Watch” or “Reserve” antibiotics (RR, 0.73 [95% CI, .60–.89]) at 90 days post evaluation. Within 6 months of site activation, 77 clinicians adopted the NAAN App.
Conclusions
Multidisciplinary adoption of inpatient penicillin DOC was safe and significantly improved penicillin prescribing and reduced use of WHO restricted antibiotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Immunology, Centre for Antibiotic Allergy and Research, Austin Health, Heidelberg, Victoria, Australia.
- Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
- National Allergy Centre of Excellence, Parkville, Victoria, Australia.
- Department of Anaesthesia, Austin Health, Heidelberg, Victoria, Australia.
- Department of Critical Care, University of Melbourne, Melbourne, Victoria, Australia.
- Data Analytics Research and Evaluation Centre, Austin Health, Heidelberg, Victoria, Australia.
ORCID-Profile: Elise A Mitri, Sara Vogrin, Richard Sullivan, Maryam Sherkat Masoum, Matthew Rawlins, Benjamin J Smith, Patricia Kilfoyle, Daniel Forster, Kylie Alcorn, Andrew Redmond, Arindam Chakravorty, Greg Weeks, Sasheela Sri La Sri Ponnampalavanar, Constance Katelaris, Indy Sandaradura, David New, Cascia Day, Natasha E Holmes, Marlena Klaic, Jason A Trubiano
Förderung
- National Allergy Centre of Excellence
- Murdoch Children's Research Institute
- Victorian Government's Operational Infrastructure Support Program
- National Health and Medical Research Council
- NHMRC Centre of Research Excellence
- Advancing Queensland Clinical Fellowship
Zitieren
APA
Mitri, E. A., Fletcher, L. R., Vogrin, S., Barnes, S., Powell, N., Peter, J., Li, P. H., Copaescu, A. M., Turner, N. A., James, F., Paynter, C., Sullivan, R., Masoum, M. S., Rawlins, M., Mackay, G., Smith, B. J., Kilfoyle, P., Forster, D., Rose, M., …, & International Network of Antibiotic Allergy Nations (iNAAN) Study Group (2026). Direct Oral Challenge for Penicillin Allergy: The International Network of Antibiotic Allergy Nations (iNAAN) Study. Clinical Infectious Diseases, 82(6), e1148-e1162. https://doi.org/10.1093/cid/ciag082
Vancouver
Mitri EA, Fletcher LR, Vogrin S, Barnes S, Powell N, Peter J, et al. Direct Oral Challenge for Penicillin Allergy: The International Network of Antibiotic Allergy Nations (iNAAN) Study. Clinical Infectious Diseases. 2026;82(6):e1148-e1162. doi:10.1093/cid/ciag082
BibTeX
@article{Mitri2026,
author = {Mitri, Elise A and Fletcher, Luke R and Vogrin, Sara and Barnes, Sara and Powell, Neil and Peter, Jonny and Li, Philip H and Copaescu, Ana Maria and Turner, Nicholas A and James, Fiona and Paynter, Camille and Sullivan, Richard and Masoum, Maryam Sherkat and Rawlins, Matthew and Mackay, Geoff and Smith, Benjamin J and Kilfoyle, Patricia and Forster, Daniel and Rose, Morgan and Cowan, Raquel and Alcorn, Kylie and Brischetto, Anna and Mahony, Andrew and Redmond, Andrew and Chakravorty, Arindam and Meher-Homji, Zaal and Yuson, Chino and Crawford, Simeon and Weeks, Greg and Ponnampalavanar, Sasheela Sri La Sri and Katelaris, Constance and Tran, Priscilla and O'Hern, Jennifer and Godsell, Jack and Peel, Trisha N and Sandaradura, Indy and New, David and Holland, Candice and Cutfield, Tim and Coghill, Sarah and Hand, Caitlin and Williams, Jacob and Bishop, Jaclyn and Lambros, Belinda and Day, Cascia and Ierano, Courtney and Roberts, Jason A and Holmes, Natasha E and Klaic, Marlena and Fernando, Suran L and Trubiano, Jason A and International Network of Antibiotic Allergy Nations (iNAAN) Study Group, International Network of Antibiotic Allergy Nations (iNAAN) Study Group},
title = {Direct Oral Challenge for Penicillin Allergy: The International Network of Antibiotic Allergy Nations (iNAAN) Study},
journal = {Clinical Infectious Diseases},
year = {2026},
volume = {82},
number = {6},
pages = {e1148--e1162},
doi = {10.1093/cid/ciag082}
}
EUVIMED